News
When Pascal Soriot flew in to speak at the Boao Forum in China this year, many expected him to keep a low profile. With ...
When Pascal Soriot flew in to speak at the Boao Forum in China this year, many expected him to keep a low profile. With ...
AstraZeneca has entered a strategic research collaboration with China's CSPC Pharmaceutical Group, aiming to accelerate the ...
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
FDA grants accelerated approval to AstraZeneca's Datroway for EGFR-mutant NSCLC after prior therapies, with a 45% response ...
A high-level overview of CSPC Pharmaceutical Group Limited (CSPCY) stock. View (CSPCY) real-time stock price, chart, news, analysis, analyst reviews and more.
AstraZeneca has penned a drug discovery pact focused on chronic diseases with China's CSPC Pharma. The FDA has halted new trials that export U.S. individuals' living cells to China. | AstraZeneca has ...
AstraZeneca signed a potential $5 billion research deal with Chinese drugmaker CSPC. Eli Lilly is buying Verve Therapeutics for $1 billion upfront plus a CVR potentially worth another $300 million.
US chemical output slows, National Resilience consolidates operations, AstraZeneca partners with a Chinese firm, and more ...
The severe asthma treatment market is experiencing robust expansion, driven by rising disease prevalence, improved diagnostic approaches, and breakthrough therapeutic developments from key ...
Under terms of the deal, CSPC will receive $110 million upfront, with potential milestone payments reaching up to $5.22 ...
Cambridge headquartered global pharmaceutical company AstraZeneca took its spending on China plays in the last month to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results